BB Biotech AG
SIX:BION.SW
36.9 (CHF) • At close November 5, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | BB Biotech AG |
Symbool | BION.SW |
Munteenheid | CHF |
Prijs | 36.9 |
Beurswaarde | 2,023,079,437 |
Dividendpercentage | 4.85% |
52-weken bereik | 35.45 - 49.8 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | 0 |
Website | https://www.bbbiotech.ch/en/bb-biotech/ |
An error occurred while fetching data.
Over BB Biotech AG
BB Biotech AG is an equity fund launched and managed by Bellevue Asset Management AG. The fund invests in the public equity markets across the globe. It primarily invests in stocks of companies that are engaged in medications and diagnostics based on modern biotechnology. The fund employs a fundamental analysis
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (CHF)
Cijfers zijn in miljoenen (CHF)